In brief
Dr. Tracy Beth Hoeg has been removed from her role as acting director of the FDA's drug center, as confirmed by an internal email. Her departure comes after weeks of leadership turmoil and follows the resignation of FDA Commissioner Marty Makary. Hoeg's tenure was marked by her controversial stances on vaccine efficacy and antidepressant safety. The FDA also named Dr. Mike Davis, her deputy, as her successor.
In a recent shake-up within the Food and Drug Administration (FDA), Dr. Tracy Beth Hoeg has been removed from her position as acting director of the agency's drug center. This decision comes after the resignation of FDA Commissioner Marty Makary, as the agency faces criticism and scrutiny over its handling of vaccine safety and other public health issues.
Dr. Hoeg, who had been in her role since December 2023, built a reputation linked with controversial stances on vaccine effectiveness and public health measures amid the COVID-19 pandemic. She announced her removal via social media, expressing no regrets about her time at the FDA.
Following Hoeg's departure, Dr. Mike Davis has been named the new acting director of the drug center. This change adds to a series of recent leadership alterations at the FDA, reflecting ongoing tensions between the agency and its critics, including political allies of former President Donald Trump.
During her brief tenure, Hoeg led inquiries into the safety of various drugs, including those related to children's health and vaccines. Her leadership was marked by significant opposition from various stakeholders, including pharmaceutical companies and public health advocates.
The FDA has now brought in Karim Mikhail, a seasoned pharmaceutical executive, to oversee its vaccine center, indicating a potential shift in the agency's strategy towards drug approval and safety assessments.
This ongoing leadership reshuffle highlights the challenges faced by the FDA as it navigates complex public health policies and the contentious reactions from different sectors of society related to health regulations.
